Neurology
-
Randomized Controlled Trial Multicenter Study
Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?
Ibudilast is a phosphodiesterase inhibitor influencing inflammation and neurodegeneration in multiple sclerosis (MS). This study evaluated the safety, tolerability, and effects on MRI parameters of 2 different doses of ibudilast in relapsing forms of MS. ⋯ This interventional study provides Class III evidence on the effect of ibudilast on disease activity.